Rockwell Medical (RMTI) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
16 Jun, 2026Opening remarks and agenda
Meeting called to order as a virtual event, enabling real-time voting and broader stockholder access.
Stockholders were reminded to use their control number to vote, with polls open briefly at the start.
Formal business included director elections, executive compensation approval, auditor ratification, and a reverse stock split amendment.
Board and executive committee updates
Leadership team members and the independent auditor were introduced and present for the meeting.
Inspector of elections and secretary roles were confirmed for meeting administration.
Corporate governance
Notice of meeting and proxy materials were mailed and made available online to all stockholders as of the record date.
Quorum established with approximately 60% of eligible shares represented by proxy.
Latest events from Rockwell Medical
- Shareholders are urged to approve a reverse stock split to help maintain Nasdaq listing.RMTI
Proxy filing11 May 2026 - Q1 2026 sales fell 8% to $17.3M, but margin improved and 2026 guidance targets profitability.RMTI
Q1 20267 May 2026 - Stockholders will vote on director elections, executive pay, auditor ratification, and a reverse stock split.RMTI
Proxy filing30 Apr 2026 - Key votes include director elections, executive pay, auditor ratification, and a reverse stock split.RMTI
Proxy filing20 Apr 2026 - Gross margin hit 21% in Q4 2025, with positive adjusted EBITDA and strong cash flow.RMTI
Q4 202526 Mar 2026 - Strong FY'25 results and margin gains support ambitious growth and profitability targets.RMTI
Investor presentation26 Mar 2026 - Rapid revenue growth, margin expansion, and automation position the company for sustained profitability.RMTI
H.C. Wainwright 3rd Annual Kidney Virtual Conference3 Feb 2026 - Q2 2024 sales rose 43% to $25.8M, with profitability and raised guidance for growth.RMTI
Q2 20242 Feb 2026 - Record Q3 sales and profit drive higher 2024 guidance, with 2025 focused on margin growth.RMTI
Q3 202415 Jan 2026